Recombinant Human Butyrophilin-like Protein 9/BTNL9 (C-Fc) | PKSH034025

Recombinant Human Butyrophilin-like Protein 9/BTNL9 (C-Fc) | PKSH034025 | Gentaur US, UK & Europe Disrtribition

Synonyms: Butyrophilin-like protein 9; BTNL9

Active Protein: N/A

Activity: Recombinant Human Butyrophilin-like Protein 9 is produced by our Mammalian expression system and the target gene encoding Ser35–Lys256 is expressed with a Fc tag at the C-terminus.

Protein Construction: Recombinant Human Butyrophilin-like Protein 9 is produced by our Mammalian expression system and the target gene encoding Ser35–Lys256 is expressed with a Fc tag at the C-terminus.

Fusion Tag: C-Fc

Species: Human

Expressed Host: Human Cells

Shipping: This product is provided as lyophilized powder which is shipped with ice packs.

Purity: > 95 % as determined by reducing SDS-PAGE.

Endotoxin: < 1.0 EU per µg as determined by the LAL method.

Stability and Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Molecular Mass: 52 kDa

Formulation: Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.

Reconstitution: Please refer to the printed manual for detailed information.

Background: Butyrophilin-Like Protein 9 (BTNL9) is single-pass type I membrane protein member of the BTN/MOG family that belongs to the immunoglobulin superfamily. BTNL9 consists of two domains: one B30.2/SPRY domain and one Ig-like V-type (immunoglobulin-like) domain. Human BTNL9 mRNA has been identified in adipose, lung, thymus, spleen, colon, and cardiac tissues, but its highest levels of expression were found in B cells. BTNL9 expression has also been found to be down-regulated in colon cancer tumors.

Research Area: N/A